Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
Clinical trial NCT00079313 · COMPLETED
Trial details
- NCT number
- NCT00079313
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-14
- Primary completion
- 2006-12-30
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.